June 30, 2017
ZURICH (Reuters) – Swiss drugmaker Roche said on Friday it is buying Vienna-based diabetes management platform mySugr for an undisclosed price as it presses into app-based digital health services for people suffering from the metabolic disorder.
MySugr, a privately held company that offers a logbook for mobile devices to help people manage their disease, had previously got funding from the Roche Venture Fund, Roche said in a statement.
Roche is among the world’s largest makers of diabetes diagnostics, including finger pricks for patients to determine blood sugar levels.
(Reporting by John Miller; Editing by Michael Shields)